Patients with stage IA HER2+ breast cancer and smaller tumors had high BCSS rates whether they received adjuvant chemotherapy or not.

The Trump Administration’s censorship extends beyond federal websites and datasets to include research to be published in academic journals.

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

The NIH said this change will save billions of dollars. Universities said it will disrupt vital, life-saving research.

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

Scientists are calling on the CDC to disclose data about the risks of bird flu that were posted briefly online last week but quickly deleted.